FASTER-HIP Study for Femoral Neck Fractures

This study, called FASTER-HIP, is looking at the best way to treat a type of hip fracture called a minimally displaced femoral neck fracture in adults aged 60 and older. It compares two surgical treatments: hip arthroplasty (a type of hip replacement surgery) and internal fixation (using screws or plates to hold the bone together). The researchers want to see if hip arthroplasty leads to better outcomes, such as reducing death, helping you walk better, and increasing the number of days you are alive and out of the hospital within 4 to 12 months after surgery. The study is currently unclear on its recruitment status and plans to enroll 600 participants.

Study design
This is a pragmatic, randomized, open-label study comparing two surgical treatments. It aims to enroll 600 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for outcomes at 120 days (about 4 months) and 12 months after randomization.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07244211

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Recruiting
NAAges 60+InterventionalTreatment
University of Southern California
~600 participants
Updated 2026-09-09 on ClinicalTrials.gov
What's tested:Hip arthroplastyInternal fixation

At a glance

Recruiting sites
20 of 26 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Composite outcome of death, ambulation status, and days alive and out of hospital.
Measured over 120 days after randomization
Femoral Neck Fractures

NCT07244211

Where you'd take part

This study runs at 26 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Beth Israel Deaconess Medical Center

    Boston, Massachusettsstudy coordinator listed

    Not yet recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, Californiastudy coordinator listed

    Recruiting

  • Consorci Sanitari de l'Alt Penedès i Garraf (CSAPG)

    Barcelona, Spainstudy coordinator listed

    Not yet recruiting

  • Fraser Health Authority

    Vancouver, British Columbia, Canadastudy coordinator listed

    Recruiting

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spainstudy coordinator listed

    Not yet recruiting

  • Indiana University

    Bloomington, Indianastudy coordinator listed

    Recruiting

  • Inova Health Care Services

    Fairfax, Virginiastudy coordinator listed

    Recruiting

  • London Health Sciences Centre

    London, Ontario, Canadastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Joseph T Patterson, MD · PRINCIPAL_INVESTIGATOR · University of Southern California

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

60 years of age or older undergoing surgery due to a minimally displaced femoral neck fracture
The patient has a health condition affecting physical mobility.
Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging.
Minimally displaced fracture that could be, in the judgment of the attending surgeon, managed with either arthroplasty or in situ internal fixation without reduction.
Low energy injury mechanism.
Surgeons with expertise in internal fixation and total hip arthroplasty or hemiarthroplasty are available to perform surgery.

Exclusion

The patient is not clinically suitable for either compared treatment.
Expected injury survival of less than 12 months.
Terminal illness with expected survival of less than 12 months.
Incarceration.
Unable to obtain informed consent due to language barriers.
Unable to obtain informed consent because the legally authorized representative was unavailable.
Problems, in the judgment of the study personnel, with maintaining follow-up with the patient.
Currently enrolled in a study or intervention domain that does not permit co-enrollment.
Prior enrollment in the specific platform trial intervention domain.
Patient or legally authorized representative did not provide informed consent (declined participation).
Eligible patient or legally authorized representative was not approached within the screening window (missed participant).
Other reasons to exclude the patient, as approved by the data coordinating center.
Associated lower extremity injury that prevents post-operative weight-bearing.
Retained hardware around the hip that precludes either study treatment.
Infection around the hip (soft tissue or bone).
Pathologic fracture with a lytic lesion in the femoral neck that precludes internal fixation.
Injury did not occur within 21 days of screening.
Patient is too ill, in the judgment of the attending surgeon, for internal fixation.
Patient is too ill, in the judgment of the attending surgeon, for arthroplasty.
  • Composite outcome of death, ambulation status, and days alive and out of hospital.120 days after randomization

    Death consists of time to all-cause mortality. Ambulation will be evaluated using an ordinal ranking of independence. Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below: * Days not alive. * Any day on which the participant had an overnight stay in a hospital, inpatient rehabilitation, skilled nursing facility, nursing home, inpatient mental health care facility, or long-term care facility.